Several studies showed loss of AR in renal cell carcinoma (RCC) in conjunction with increasing clinical stage and pathological grade, but others found that higher AR expression correlated with worse outcomes. The gene discussed is AR; the disease is hereditary clear cell renal cell carcinoma.